The beers criteria - An instrument to optimise the pharmacotherapy of geriatric patients;Die beers-liste - Ein instrument zur optimierung der arzneimitteltherapie geriatrischer patienten

Medizinische Monatsschrift fur Pharmazeuten

Volumn 30, Issue 7, 2007, Pages 244-248

  Schwalbe, Oliver ^a   Freiberg, Ines ^a   Kloft, Charlotte ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ALPRAZOLAM; AMFEPRAMONE; AZELASTINE; BISACODYL; CIMETIDINE; CLEMASTINE FUMARATE; CYCLANDELATE; CYPROHEPTADINE; DIGOXIN; DIMETINDENE; DOXAZOSIN; DOXYLAMINE; EBASTINE; FLUOXETINE; HYDROXYZINE; KETOROLAC; KETOTIFEN FUMARATE; LORAZEPAM; MEQUITAZINE; METHOCARBAMOL; METHYLPHENIDATE; MIZOLASTINE; NIFEDIPINE; ORPHENADRINE CITRATE; OXAZEPAM; PETHIDINE; PROMETHAZINE; QUAZEPAM; TEMAZEPAM; TRIAZOLAM; UNINDEXED DRUG;

CONSENSUS; CONSTIPATION; GERIATRIC CARE; HUMAN; HYPOTENSION; PATIENT CARE; PATIENT COUNSELING; PHARMACEUTICAL CARE; REVIEW;

AGED; GERIATRICS; HUMANS; PHARMACEUTICAL SERVICES;

EID: 34547212388     PISSN: 03429601     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Statistisches Bundesamt Deutschland. Koordinierte Bevölkerungs- vorausberechnung. http://www.destat.de 2007
2. Schneemann H, Young LY, Koda-Kimble MA. Angewandte Arzneimitteltherapie. Heidelberg: Springer, 2001.
3. Högger P, Strehl E. Repetitorium Klinische Pharmazie. Eschborn: GoviVerlag, 2007.
4. Beers MH, Ouslander JG, Rollingher I, Reuben DB, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991;151:1825-32.
5. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997;157:1531-6.
6. Fick DM, Cooper JW, Wade WE, Waller JL, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163:2716-24.
7. st ed. London: Pharmaceutical Press, 2002.
8. Rote Liste. Aulendorf: Editio Cantor Verlag, 2006.
9. Aggrenox®-Fachinformation: Boehringer-Ingelheim Pharma, Ingelheim am Rhein, Februar 2006.
10. de Oliveira Martins S, Soares MA, Foppe van Mil JW, Cabrita J. Inappropriate drug use by Portuguese elderly outpatients - effect of the Beers criteria update. Pharm World Sci 2006;28:296-301.
11. Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005;293:1348-58.
12. Maio V, Yuen EJ, Novielli K, Smith KD, et al. Potentially inappropriate medication prescribing for elderly outpatients in Emilia Romagna, Italy: a population-based cohort study. Drugs Aging 2006;23:915-24.
13. van der Hooft CS, Jong GW, Dieleman JP, Verhamme KM, et al. Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria - a population-based cohort study. Br J Clin Pharmacol 2005;60: 137-44.
14. Schaefer M, Schulz M. Band 1 Grundlagen der Pharmazeutischen Betreuung. Eschborn: Govi-Verlag, 2000.
15. Carnahan RM, Lund BC, Perry PJ, Pollock BG, et al. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol 2006;46:1481-6.
16. Unangemessene Medikamente bei älteren Patienten. Arzneimittelbrief 2005;39:44.
17. Lennecke K, Beinicke SM, Hagel K, Grasmäder K, et al. Therapieprofile für die Kitteltasche. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH, 2006.
18. Crownover BK, Unwin BK. Implementation of the Beers criteria: sticks and stones - or throw me a bone. J Manag Care Pharm 2005;11:416-7.
19. Zylka-Menhorn V. Geriatrisierung ist notwendig. Dtsch Ärztebl 2007;104:77.
20. Siebert CD. Der Risiko-Check mit CAVE. Pharm Ztg 2004;149:28-32.